High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$47.4M
$47,398,246
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-02 | $1,627,534Largex4 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-23 | $1,576,606Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-04 | $872,913x2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Coyne Terrance P.
• CFO
10b5-1 SellΔOwn -20.5%
2026-02-03
$4,924,997Largex2
|
||||||
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -20.5%
|
2026-02-03 | $4,924,997Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Coyne Terrance P.
• CFO
10b5-1 SellΔOwn -16.2%
2026-02-02
$4,562,905Largex2
|
||||||
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -16.2%
|
2026-02-02 | $4,562,905Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 Sell
2026-01-30
$821,810
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 Sell
|
2026-01-30 | $821,810 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -50.0%
2026-01-23
$805,110
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -50.0%
|
2026-01-23 | $805,110 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-01-20 | $2,737,940Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -33.3%
2026-01-16
$790,346
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -33.3%
|
2026-01-16 | $790,346 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -25.0%
2026-01-09
$815,634
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -25.0%
|
2026-01-09 | $815,634 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -14.3%
2025-12-19
$767,582
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -14.3%
|
2025-12-19 | $767,582 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 Sell
2025-12-18
$1,180,053Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 Sell
|
2025-12-18 | $1,180,053Large | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -72.1%
2025-12-17
$3,060,280Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -72.1%
|
2025-12-17 | $3,060,280Large | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -12.5%
2025-12-16
$766,420
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -12.5%
|
2025-12-16 | $766,420 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-15 | $2,669,172Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -50.0%
2025-12-03
$4,375,008Large
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -50.0%
|
2025-12-03 | $4,375,008Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-01 | $2,773,956Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Urist Marshall
• Officer • EVP, Research & Investments
10b5-1 SellΔOwn -11.3%
2025-12-01
$1,659,489Largex2
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Research & Investments
10b5-1 SellΔOwn -11.3%
|
2025-12-01 | $1,659,489Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $2,682,505Largex4 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Lloyd George W.
• Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -43.2%
2025-11-19
$5,192,656Whalex8
|
||||||
| RPRX |
Royalty Pharma plc
|
Officer • EVP, Investments & CLO
10b5-1 SellΔOwn -43.2%
|
2025-11-19 | $5,192,656Whalex8 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-17 | $2,735,329Largex2 | S | Form 4 |